European Archives - Page 271 of 1218 - European Medical Journal

What Drives Upper Extremity Disability in Early Rheumatoid Arthritis?

Upper extremity disability in rheumatoid arthritis fluctuates over time, with pain and hand function playing a critical role, study finds.

Largest Genetic Study of Epilepsy Reveals New Treatment Targets

This new research sheds light on shared and subtype-specific genetic variations and points to potential targets

Restaging MRI Predicts Outcomes in Locally Advanced Rectal Cancer After Neoadjuvant Therapy

Restaging MRI is a powerful tool for predicting survival and organ preservation in rectal cancer patients after total neoadjuvant therapy…

Emerging Artemisinin Resistance in Children with Complicated Malaria

Research highlights the emergence of artemisinin partial resistance in Ugandan children with complicated malaria, a development with significant implications for treatment protocols in high-burden regions.

Risk Score Predicts GI Bleeding in Post-PCI Patients

New research highlights the utility of the PRECISE-DAPT score in predicting GI bleeding risk in patients undergoing dual antiplatelet therapy after percutaneous coronary intervention.

Teledermoscopy: Bridging Gaps in Early Melanoma Detection

This study reinforces teledermoscopy’s utility for triaging skin lesions and prioritising high-risk cases for in-person care.

Ultrasound Renal Denervation Shows Long-Term Success in Hypertension

Ultrasound renal denervation delivers long-term blood pressure reductions and reduces medication reliance in resistant hypertension, study reveals.

Low Visceral Fat Increases Risk of Post-Operative Neurogenic Bladder

Postoperative neurogenic bladder significantly impacts patients’ quality of life, necessitating prolonged catheter use in up to 16% of cases.

Higher COVID-19 Risks for People with Multiple Conditions

COVID-19 poses significantly higher risks for people with multiple long-term conditions, with increased rates of mortality and severe outcomes.

Handshake on blue background

FDA greenlights UCB’s IL-17 inhibitor for HS

The novel IL-17A and IL-17F inhibitor has been approved the treatment of moderate to severe hidradenitis suppurativa, a chronic and painful skin disease.